Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

First-In-Human Robot-Assisted Subretinal Drug Delivery Under Local Anaesthesia A Randomised Clinical Trial.

Journal article

Cehajic-Kapetanovic J. et al, (2021), Am J Ophthalmol

Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina.

Journal article

Chandler LC. et al, (2021), Mol Ther Methods Clin Dev, 22, 52 - 65

Expression of Rab Prenylation Pathway Genes and Relation to Disease Progression in Choroideremia.

Journal article

Fry LE. et al, (2021), Transl Vis Sci Technol, 10

Flying baby optical coherence tomography alters the staging and management of advanced retinopathy of prematurity.

Journal article

Cehajic-Kapetanovic J. et al, (2021), Acta Ophthalmol, 99, 441 - 447

Genome-Editing Strategies for Treating Human Retinal Degenerations.

Journal article

Quinn J. et al, (2021), Hum Gene Ther, 32, 247 - 259

CRISPR genome engineering for retinal diseases.


Kantor A. et al, (2021), 182, 29 - 79

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?

Journal article

Han RC. et al, (2021), Expert Opin Orphan Drugs, 9, 13 - 24

Highest reported visual acuity after electronic retinal implantation.

Journal article

Cehajic Kapetanovic J. et al, (2020), Acta Ophthalmol, 98, 736 - 740

Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases.

Journal article

Xue K. and MacLaren RE., (2020), Expert Opin Investig Drugs, 29, 1163 - 1170

Correcting visual loss by genetics and prosthetics.

Journal article

Xue K. and MacLaren RE., (2020), Curr Opin Physiol, 16, 1 - 7

Cell-Mediated Inflammatory Response to AAV Gene Therapy in the Retina

Conference paper

Chandler LC. et al, (2020), MOLECULAR THERAPY, 28, 515 - 516

Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR.

Journal article

Cehajic-Kapetanovic J. et al, (2020), Nat Med, 26, 354 - 359

The Impact of Progressive Visual Field Constriction on Reading Ability in an Inherited Retinal Degeneration.

Journal article

Jolly JK. et al, (2020), Ophthalmologica, 243, 207 - 216

Looking towards gene therapy: Characterisation of ex vivo AAV2.CYP4V2 gene therapy in human retinal explants

Conference paper


Load More